Omisirge: A Groundbreaking Advancement in Cord Blood Stem Cell Treatment
Important Note: Americord is not affiliated with Gamida Cell or the Omisirge product. At this [...]
Important Note: Americord is not affiliated with Gamida Cell or the Omisirge product. At this [...]
February 16, 2022 - A woman of mixed race is the first to be cured [...]
Americord Registry®, a leading provider of umbilical cord blood, cord tissue, and placental tissue banking, [...]
Americord Registry, a leading provider of stem cell and cord blood storage, today announced [...]
During the height of the pandemic, specifically in May of 2020, we at Americord [...]
Americord is the best quality cord blood bank. We are competitively priced towards our major [...]
In phase 1 of a clinical trial at the Harvard Stem Cell Institute (HSCI), Harvard [...]
49% of expectant parents are aware but, minimally informed about cord blood banking. How much [...]
Americord Yields 60% More CD34+ Stem Cells, 54% More Cord Blood, and 34% Higher TNC [...]
This original article was posted on Baby Proofed Parents and written by Kirsten Brunner, MA, LPC. Twelve [...]